---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-021941"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:29:39.467808+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology appoints Dr. Brian Alexander to board, replacing Dr. Philip Breitfeld

## Summary
- Board accepted resignation of Dr. Philip Breitfeld and appointed Dr. Brian Alexander effective March 24, 2026.
- Dr. Alexander is CEO of Valo Health and CEO-Partner at Flagship Pioneering; formerly CEO of Foundation Medicine.
- Appointment supports Champions' strategy to integrate patient-derived tumor models with molecular data for AI-driven R&D.
- Dr. Breitfeld's resignation was not due to any disagreement with the company's operations or policies.

## SEC filing metadata
- accession: 0001628280-26-021941
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828026021941/0001628280-26-021941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828026021941/csbr-20260324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-021941
- JSON: https://secwatch.observer/filing/0001628280-26-021941.json
- Plain text: https://secwatch.observer/filing/0001628280-26-021941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.